Main Menu

News and features

The Institute of Cancer Research, London, media team works to increase the profile of the organisation by showcasing the cutting-edge research carried out by our scientists and development initiatives. 

For more information you can always contact our media team, or visit our press release archive to view a list of our press releases. 


Cancer research technology pioneer fund boosts investment in drugs that block cancer defences 05

The Cancer Research Technology (CRT) Pioneer Fund has today (Thursday) announced its investment in research to develop new drugs called heat-shock factor 1 (HSF1) pathway inhibitors, which have the potential to block a protective mechanism used by cancer cells. Find out more

Gruelling cycle ride raises over £190,000 for cancer research 04

Tim Morgan has faced an extraordinary challenge this month in a cycle ride pitched as the 'hardest event in the Cycling Weekly Sportive Series' to raise funds for cancer research. His amazing efforts have already raised over £190,000. Find out more

Pioneering cancer researcher takes on charity cycle in memory of his colleague 04

Pioneering cancer researcher Professor Richard Marais is taking on a 112-mile cycle challenge to raise funds in memory of Professor Chris Marshall – an outstanding and inspirational scientist whose work led to the development of new cancer treatments. Find out more

See all news articles


Watch: How cancers turn healthy cells to the ‘dark side’ 14

Through images and video, we explain new research that shows cancer cells use a mutant gene to coerce neighbouring healthy tissue into helping with the disease’s growth and spread. Find out more

Seeking kinder ways to tackle childhood cancer 24

Our research could reshape how we treat rhabdomyosarcoma, making huge, long-lasting improvements to young patients’ lives. Liz Burtally finds out how. Find out more

Moving away from the ‘one fraction size fits all' approach to radiotherapy 25

Researchers are discovering biological markers that can predict the sensitivity of tumours to radiotherapy, with the potential to tailor dosing to individual patients, finds Liz Burtally. Find out more

See all feature articles
We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.